---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-043281"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T12:12:35.774630+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# USANA Q3 net sales $200M (-6% YoY); cuts FY2024 EPS guidance to $2.45

## Summary
- Q3 diluted EPS $0.56 vs $0.59 YoY; net sales down 6% to $200M.
- Active customers fell 3% YoY to 452,000; Greater China customers rose 6% but sales -4%.
- FY2024 outlook narrowed: net sales ~$850M (from $850-880M), EPS $2.45 (from $2.40-2.55).
- Balance sheet: $365M cash, debt-free; no shares repurchased in Q3.
- Regional weakness: North Asia -15%, Americas & Europe -7% YoY.

## SEC filing metadata
- accession: 0001628280-24-043281
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000162828024043281/0001628280-24-043281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000162828024043281/usna-20241022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-043281
- JSON: https://secwatch.observer/filing/0001628280-24-043281.json
- Plain text: https://secwatch.observer/filing/0001628280-24-043281.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.